MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Z.
Right arrow Articles by Uhl, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Z.
Right arrow Articles by Uhl, G. R.

Vol. 56, Issue 2, 434-447, August 1999

Dopamine Transporter: Transmembrane Phenylalanine Mutations Can Selectively Influence Dopamine Uptake and Cocaine Analog Recognition

Zhicheng Lin, Wenfei Wang, Theresa Kopajtic, Randal S. Revay, and George R. Uhl

Molecular Neurobiology Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health (Z.L., W.W., T.K., R.S.R., G.R.U.); and Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland (G.R.U.)

Cocaine blocks the normal role of the dopamine transporter (DAT) in terminating dopamine signaling through molecular interactions that are only partially understood. Cocaine analog structure-activity studies have suggested roles for both cationic and aromatic interactions among DAT, dopamine, and cocaine. We hypothesized that phenylalanine residues lying in putative DAT transmembrane (TM) domains were good candidates to contribute to aromatic and/or cationic interactions among DAT, dopamine, and cocaine. To test this idea, we characterized the influences of alanine substitution for each of 29 phenylalanine residues lying in or near a putative DAT TM domain. Cells express 22 mutants at near wild-type levels, manifest by DAT immunohistochemistry and binding of the radiolabeled cocaine analog [3H](-)-2-beta -carbomethoxy-3-beta -(4-fluorophenyl)tropane (CFT). Seven mutants fail to express at normal levels. Four mutations selectively reduce cocaine analog affinities. Alanine substitutions at Phe76, Phe98, Phe390, and Phe361 located in TM domains 1 and 2, the fourth extracellular loop near TM 4 and in TM 7, displayed normal affinities for dopamine but 3- to 8-fold reductions in affinities for CFT. One TM 3 mutation, F155A, selectively decreased dopamine affinity to less than 3% of wild-type levels while reducing CFT affinity less than 3-fold. In a current DAT structural model, each of the residues at which alanine substitution selectively reduces cocaine analog or dopamine affinities faces a central transporter cavity, whereas mutations that influence expression levels are more likely to lie at potential helix/helix interfaces. Specific, overlapping sets of phenylalanine residues contribute selectively to DAT recognition of dopamine and cocaine.

Copyright © 1999 by U.S. Government


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
M. L. Parnas, J. D. Gaffaney, M. F. Zou, J. R. Lever, A. H. Newman, and R. A. Vaughan
Labeling of Dopamine Transporter Transmembrane Domain 1 with the Tropane Ligand N-[4-(4-Azido-3-[125I]iodophenyl)butyl]-2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)tropane Implicates Proximity of Cocaine and Substrate Active Sites
Mol. Pharmacol., April 1, 2008; 73(4): 1141 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. Vaughan, D. S. Sakrikar, M. L. Parnas, S. Adkins, J. D. Foster, R. A. Duval, J. R. Lever, S. S. Kulkarni, and A. Hauck-Newman
Localization of Cocaine Analog [125I]RTI 82 Irreversible Binding to Transmembrane Domain 6 of the Dopamine Transporter
J. Biol. Chem., March 23, 2007; 282(12): 8915 - 8925.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. K. Hahn, M. S. Mazei-Robison, and R. D. Blakely
Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation
Mol. Pharmacol., August 1, 2005; 68(2): 457 - 466.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Miranda, T. Sorkina, T. N. Grammatopoulos, W. M. Zawada, and A. Sorkin
Multiple Molecular Determinants in the Carboxyl Terminus Regulate Dopamine Transporter Export from Endoplasmic Reticulum
J. Biol. Chem., July 16, 2004; 279(29): 30760 - 30770.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Sato, Y.-W. Zhang, A. Androutsellis-Theotokis, and G. Rudnick
Analysis of Transmembrane Domain 2 of Rat Serotonin Transporter by Cysteine Scanning Mutagenesis
J. Biol. Chem., May 28, 2004; 279(22): 22926 - 22933.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. W. Ravna, I. Sylte, and S. G. Dahl
Molecular Mechanism of Citalopram and Cocaine Interactions with Neurotransmitter Transporters
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 34 - 41.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Lin, P.-W. Zhang, X. Zhu, J.-M. Melgari, R. Huff, R. L. Spieldoch, and G. R. Uhl
Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites
J. Biol. Chem., May 23, 2003; 278(22): 20162 - 20170.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
X. Wu and H. H. Gu
Cocaine Affinity Decreased by Mutations of Aromatic Residue Phenylalanine 105 in the Transmembrane Domain 2 of Dopamine Transporter
Mol. Pharmacol., March 1, 2003; 63(3): 653 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z. Lin and G. R. Uhl
Dopamine Transporter Mutants with Cocaine Resistance and Normal Dopamine Uptake Provide Targets for Cocaine Antagonism
Mol. Pharmacol., April 1, 2002; 61(4): 885 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. Sora, F. S. Hall, A. M. Andrews, M. Itokawa, X.-F. Li, H.-B. Wei, C. Wichems, K.-P. Lesch, D. L. Murphy, and G. R. Uhl
Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference
PNAS, April 24, 2001; 98(9): 5300 - 5305.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
R. A. Vaughan, J. D. Gaffaney, J. R. Lever, M. E. A. Reith, and A. K. Dutta
Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains
Mol. Pharmacol., April 16, 2001; 59(5): 1157 - 1164.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
Z. Lin, W. Wang, and G. R. Uhl
Dopamine Transporter Tryptophan Mutants Highlight Candidate Dopamine- and Cocaine-Selective Domains
Mol. Pharmacol., April 13, 2001; 58(6): 1581 - 1592.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
E. M. Adkins, E. L. Barker, and R. D. Blakely
Interactions of Tryptamine Derivatives with Serotonin Transporter Species Variants Implicate Transmembrane Domain I in Substrate Recognition
Mol. Pharmacol., March 1, 2001; 59(3): 514 - 523.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
M. M. Francis, R. W. Vazquez, R. L. Papke, and R. E. Oswald
Subtype-Selective Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Cocaine Is Determined by the alpha 4 and beta 4 Subunits
Mol. Pharmacol., July 1, 2000; 58(1): 109 - 119.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
M. Itokawa, Z. Lin, N.-S. Cai, C. Wu, S. Kitayama, J.-B. Wang, and G. R. Uhl
Dopamine Transporter Transmembrane Domain Polar Mutants: Delta G and Delta Delta G Values Implicate Regions Important for Transporter Functions
Mol. Pharmacol., June 1, 2000; 57(6): 1093 - 1103.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
J. Ponce, B. Biton, J. Benavides, P. Avenet, and C. Aragon
Transmembrane Domain III Plays an Important Role in Ion Binding and Permeation in the Glycine Transporter GLYT2
J. Biol. Chem., April 28, 2000; 275(18): 13856 - 13862.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Z. LIN, M. ITOKAWA, and G. R. UHL
Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression
FASEB J, April 1, 2000; 14(5): 715 - 728.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
G. Kamdar, K. M. Y. Penado, G. Rudnick, and M. M. Stephan
Functional Role of Critical Stripe Residues in Transmembrane Span 7 of the Serotonin Transporter. EFFECTS OF Na+, Li+, AND METHANETHIOSULFONATE REAGENTS
J. Biol. Chem., February 2, 2001; 276(6): 4038 - 4045.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics